Metabolomics, metabolic flux analysis and cancer pharmacology
Metabolic reprogramming is a hallmark of cancer and increasing evidence suggests that reprogrammed cell metabolism supports tumor initiation, progression, metastasis and drug resistance. Understanding metabolic dysregulation may provide therapeutic targets and facilitate drug research and developmen...
Saved in:
Published in | Pharmacology & therapeutics (Oxford) Vol. 224; p. 107827 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Inc
01.08.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!